This news is delayed by 15 minutes, sign up now to get live news & full features.
QURE UNIQURE NV
+ add to watchlist
$26.15
uniqure is delivering on the promise of gene therapy - single treatments with potentially curative results. we are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.
Mkt Cap: $1.66B
52 Week High: $71.50
P/E: -1.00
52 Week Low: $6.11
Dividend: $0.00
Shares Outstanding: 62.29M